XML 55 R5.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
6 Months Ended
Feb. 28, 2015
Feb. 28, 2014
Cash flows from operating activities    
Net income $ 1,499,136us-gaap_NetIncomeLoss $ 1,495,019us-gaap_NetIncomeLoss
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation and amortization of property and equipment 112,441us-gaap_DepreciationDepletionAndAmortization 23,873us-gaap_DepreciationDepletionAndAmortization
Amortization of capitalized computer software development costs 490,051us-gaap_CapitalizedComputerSoftwareAmortization 383,652us-gaap_CapitalizedComputerSoftwareAmortization
Amortization of Intellectual property 303,750us-gaap_AmortizationOfIntangibleAssets 3,750us-gaap_AmortizationOfIntangibleAssets
Stock-based compensation 150,624us-gaap_ShareBasedCompensation 71,087us-gaap_ShareBasedCompensation
Deferred income taxes 159,968us-gaap_DeferredIncomeTaxExpenseBenefit 101,086us-gaap_DeferredIncomeTaxExpenseBenefit
(Increase) decrease in    
Accounts receivable (536,612)us-gaap_IncreaseDecreaseInAccountsReceivable (711,477)us-gaap_IncreaseDecreaseInAccountsReceivable
Revenues in excess of billings (92,310)us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract 0us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract
Prepaid income taxes 422,125us-gaap_IncreaseDecreaseInPrepaidExpense (38,739)us-gaap_IncreaseDecreaseInPrepaidExpense
Prepaid expenses and other assets 8,095us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets 14,629us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
Accounts payable (69,307)us-gaap_IncreaseDecreaseInAccountsPayable 160,712us-gaap_IncreaseDecreaseInAccountsPayable
Accrued payroll and other expenses (397,090)us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities 3,086us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities
Accrued bonus (72,000)us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities 0us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities
Billings in excess of revenues (249,637)us-gaap_IncreaseDecreaseInBillingInExcessOfCostOfEarnings 0us-gaap_IncreaseDecreaseInBillingInExcessOfCostOfEarnings
Other liabilities (9,930)us-gaap_IncreaseDecreaseInOtherCurrentLiabilities (9,929)us-gaap_IncreaseDecreaseInOtherCurrentLiabilities
Deferred revenue 14,576us-gaap_IncreaseDecreaseInDeferredRevenue 154,161us-gaap_IncreaseDecreaseInDeferredRevenue
Net cash provided by operating activities 1,807,630us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations 1,650,910us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash flows from investing activities    
Purchases of property and equipment (19,159)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (18,353)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Cash used to purchase Cognigen (2,080,000)us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates 0us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates
Cash received in acquisition 190,184us-gaap_CashAcquiredFromAcquisition 0us-gaap_CashAcquiredFromAcquisition
Capitalized computer software development costs (730,855)us-gaap_PaymentsToDevelopSoftware (733,454)us-gaap_PaymentsToDevelopSoftware
Net cash provided by (used in) investing activities (2,639,830)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations (751,807)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
Cash flows from financing activities    
Payment of Dividends (1,684,660)us-gaap_PaymentsOfDividends (1,450,429)us-gaap_PaymentsOfDividends
Proceeds from the exercise of stock options 4,973us-gaap_ProceedsFromStockOptionsExercised 73,445us-gaap_ProceedsFromStockOptionsExercised
Net cash (used in) financing activities of continuing operations (1,679,687)us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations (1,376,984)us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Net increase (decrease) in cash and cash equivalents (2,511,887)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (477,881)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents, beginning of year 8,614,929us-gaap_CashAndCashEquivalentsAtCarryingValue 10,179,298us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents, end of period 6,103,042us-gaap_CashAndCashEquivalentsAtCarryingValue 9,701,417us-gaap_CashAndCashEquivalentsAtCarryingValue
Supplemental disclosures of cash flow information    
Interest paid 0us-gaap_InterestPaid 0us-gaap_InterestPaid
Income taxes paid 76,519us-gaap_IncomeTaxesPaid 572,192us-gaap_IncomeTaxesPaid
Non-Cash Investing and Financing    
Stock issued for acquisition of Cognigen Corporation 3,277,170us-gaap_StockIssuedDuringPeriodValueAcquisitions 0us-gaap_StockIssuedDuringPeriodValueAcquisitions
Creation of contract liability for acquisition of Cognigen Corporation $ 1,854,405simu_CreationOfContractLiabilityForAcquisitionOfCognigenCorporation $ 0simu_CreationOfContractLiabilityForAcquisitionOfCognigenCorporation